Investing carries serious risks, including partial or total loss of capital. Please read the Key Investment Information Sheet and the Risk factors and login before investing.

Blue Armor 1A

What if vaccinating fish was the key to more profitable and sustainable aquaculture?
Key Investment Information Sheet Terms & Conditions
€120,500
total amount raised in round
482%
Financed 482%
  • Eligible for a tax reduction
The BLUE ARMOR 1A compartment of Spreds Finance would participate in the financing of BLUE ARMOR BV/SRL planned between € 100,000 and €1,000,000 (the "Capital Increase").
 
Of the total amount raised during the period of the offering, Spreds Finance will use an amount of €1 per Participatory Notes for these purposes, subject to the fulfilment of the conditions for such placement.
 

Cumulative conditions precedent

 
The minimum subscription amount per investor is €500.
The minimum offering amount is €25,000.
 
The Notes will only be issued if, within 6 months from the Closing Date, the following listed cumulative and conditions precedent to the subscription of shares of BLUE ARMOR by Spreds Finance (see below) are met:
 
 - The total amount of commitments to subscribe to this Capital Increase is at least € 100,000 and not more than € 1,000,000.
 
 - The Capital increase is based on a maximum pre-money valuation of €1,168,278.
 
 - The BLUE ARMOR 1A compartment of Spreds Finance participates in the Capital Increase in an amount equal to the result of the subscription of Notes of the BLUE ARMOR 1A compartment. This amount must be a minimum of €25,000.
 
Spreds Finance verifies that such conditions precedent are met no later than 6 months after the Closing Date ("Effective Date"), i.e. 15/05/2026. In the event that one or more of these conditions are not met by the Effective Date, the Notes will not be issued and the Subscription Amount paid by the Investors respectively will be refunded no later than 15 business days after the Effective Date.
 

Subscription period

 
The subscription period begins on 15/08/2025 and ends on the Closing Date, which is in principle 15/11/2025.
 
It may be decided to extend the subscription period by 3 months (until 15/02/2026 at the latest), if the total amount of subscriptions on 15/11/2025 is at least €20,000.
 
The offering may be closed early once the minimum offering amount, of €25,000, has been reached.
 
The Participatory Notes will be issued on the date of the capital increase, if the conditions for issuing these Participatory Notes are met. That is, at the latest on 15/05/2026 if the subscription period ends on 20/05/2025. This may be earlier (if the offering closes early) or later (if the subscription period is extended).
 

Tax Shelter (45%)

 
This investment opportunity is eligible for an income tax reduction for Belgian investors under the Belgian tax incentive system, the Start-Up Tax Shelter.
 
The maximum reduction of 45% of the total nominal amount invested in Participatory Notes is applicable because the underlying assets are the shares of a micro-enterprise.
 
This means that the total tax benefit will amount to a maximum of €0,45 per Participatory Note subscribed by the investor.
 
The budget available for Tax Shelter is €500,000.


Scorecard


The Scorecard is a tool designed to help investors make more informed decisions when considering investments in start-up companies. It provides an overview of a company's current situation. Developed by Spreds, it offers an objective score based on a defined set of key factors, often identified by academic research as indicators of a start-up's potential for success. The documents provided by BLUE ARMOR were received by Spreds and made available to (potential) investors. The content of these documents was not analyzed by Spreds nor Spreds Finance.


Download BA_Business_Plan.pdf 627 KB

Download SWOT Analysis Blue Armor July 2025.pdf 70.7 KB

Download Plan_financier___Blue_Armor_SRL.pdf 363 KB

Download Main Process - Blue Armor.pdf 154 KB

Download Competencies and HR needs Blue Armor.pdf 127 KB

Download Blue_Armor-Viral Vaccines strategy v7.2- NC.pdf 2.7 MB

Download 9066 - RNA VACC - BLUE ARMOR - Budget Amor_COUC.xlsx 69.4 KB
Download 9066 - RNA VACC - BLUE ARMOR - Budget Perso_COUC.xlsx 71.5 KB
Download 9066 - RNA VACC - BLUE ARMOR - Budget ST_COUC.xlsx 55.8 KB

Download 9066 - RNA VACC - BLUE ARMOR - Budget Total_COUC.xlsx 68 KB
Download Worst Case Scenario - rNPV Vaccine - Blue Armor - 060225.xlsx 28 KB

Download Best_Case_Scenario___rNPV_Vaccine____Blue_Armor___060225.xlsx 27.9 KB

Download Investor_presentation_Blue Armor.pdf 939 KB

TAX SHELTER 45%

Investments in this company benefit from a 45% personal income tax reduction. Read more…
A remaining amount of €380,500 is available for the Tax Shelter benefit.

Raise summary

Crowd investments €120,500
Committed by others €0
Amount raised €120,500
Minimum round €100,000
Maximum round €1,000,000
Shares in the company (total round) 46.12%
Pre-money valuation €1,168,278
Post-money valuation min. €1,268,278
Post-money valuation max. €2,168,278